Joel Greenblatt's position in Astrazeneca plc is currently worth $521k. That's 0.00% of their equity portfolio (1455th largest holding). The first Astrazeneca plc trade was made in Q4 2010. Since then Joel Greenblatt bought shares eight more times and sold shares on six occasions. The stake costed the investor $229k, netting the investor a gain of 128% so far.